MedImmune LLC:企業のM&A・事業提携・投資動向

◆英語タイトル:MedImmune LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1407
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:427
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

MedImmune LLC – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s MedImmune LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by MedImmune LLC since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes MedImmune LLC’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by MedImmune LLC. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on MedImmune LLC’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by MedImmune LLC and its subsidiaries since 2007.
- Information about key financial and legal advisors for MedImmune LLC’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about MedImmune LLC’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 27
Corporate Venturing – Overview 27
Corporate Venturing – Deal reports 28
PARTNERSHIP 35
Partnership – Overview 35
Partnership – Deal reports 36
PRIVATE EQUITY & OWNERSHIP 411
Private Equity and Ownership – Deal reports 411
APPENDIX 417
Contact Us 417
About MarketLine Financial Deals Database 417
Deal Definition and Methodology 419
About MarketLine 426

List of Tables
Table 1: MedImmune LLC M&A volume and value trend (2014-YTD2018)
Table 2: MedImmune LLC M&A activity by geography (2014-YTD2018)
Table 3: MedImmune LLC corporate venturing volume and value trend (2014-YTD2018)
Table 4: MedImmune LLC corporate venturing by geography (2014-YTD2018)
Table 5: MedImmune LLC partnership volume and value trend (2014-YTD2018)
Table 6: MedImmune LLC partnership trend by key deal type (2014-YTD2018)

List of Figures
Figure 1: MedImmune LLC M&A volume and value trend (2014-YTD2018)
Figure 2: MedImmune LLC M&A activity by geography (2014-YTD2018)
Figure 3: MedImmune LLC corporate venturing volume and value trend (2014-YTD2018)
Figure 4: MedImmune LLC corporate venturing by geography (2014-YTD2018)
Figure 5: MedImmune LLC partnership volume and value trend (2014-YTD2018)
Figure 6: MedImmune LLC partnership trend by key deal type (2014-YTD2018)

★海外企業調査レポート[MedImmune LLC:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hutchison 3G UK Limited:企業の戦略・SWOT・財務分析
    Hutchison 3G UK Limited - Strategy, SWOT and Corporate Finance Report Summary Hutchison 3G UK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Cidara Therapeutics Inc (CDTX):企業の財務・戦略的SWOT分析
    Summary Cidara Therapeutics Inc (Cidara), formerly K2 Therapeutics Inc is a biotechnology company that discovers, develops and commercializes novel anti-infectives including immunotherapies. The company's pipeline products include novel echinocandin CD101 IV, for the treatment of systemic candida in …
  • Scomi Group Bhd (SCOMI):企業の財務・戦略的SWOT分析
    Scomi Group Bhd (SCOMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • SpringWorks Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary SpringWorks Therapeutics LLC (SpringWorks Therapeutics) is a drug development company that develops therapeutic medicines for various diseases. The company’s pipeline products include Nirogacestat, MEK ½ Inhibitor, Senicapoc and FAAH Inhibitor. Its Nirogacestat is a gamma secretase inhibitor …
  • AEON Credit Service (M) Berhad:企業の戦略・SWOT・財務情報
    AEON Credit Service (M) Berhad - Strategy, SWOT and Corporate Finance Report Summary AEON Credit Service (M) Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sanofi (SAN)-製薬・医療分野:企業M&A・提携分析
    Summary Sanofi is a healthcare company, which focuses on the research, development, manufacture and marketing a wide range of medicines and vaccines. Its product portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; human v …
  • Advocate Health Care:製薬・医療:M&Aディール及び事業提携情報
    Summary Advocate Health Care (Advocate Health) is a nonprofit health system that provides health care services. It provides health care services such as inpatient acute and non-acute care, primary and specialty physician services and various outpatient services to communities in Illinois. The organi …
  • mAbxience SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Mabxience SA (mAbxience), a subsidiary of Chemo Espana SA, is a biotechnology company that research, develops and manufactures biosimilar monoclonal antibodies. The company develops biosimilars, which are used for the treatment and prevention of various diseases in onclology such as breast c …
  • Commercial Bank Of Ceylon Plc
    Commercial Bank Of Ceylon Plc - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank Of Ceylon Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Safety-Kleen Inc:企業の戦略的SWOT分析
    Safety-Kleen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Total Energy Services Inc. (TOT):企業の財務・戦略的SWOT分析
    Total Energy Services Inc. (TOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Eagle Bancorp Inc:企業の戦略・SWOT・財務分析
    Eagle Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Eagle Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Marksmen Energy Inc (MAH):企業の財務・戦略的SWOT分析
    Summary Marksmen Energy Inc (Marksmen Energy), formerly Marksmen Resources Ltd, is an oil and gas exploration and development company that explores and develops light oil assets in Ohio. The company acquires, explores, operates, manages, produces and develops oil and gas properties in Western Canada …
  • Canadian Energy Services & Technology Corp (CEU):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Energy Services & Technology Corp (CES) is a provider of chemical solutions. It provides technically advanced consumable chemical solutions for the North American oil and gas industry. The total solution provided by the company includes the drill-bit, at the point of completion and …
  • Banco Nacional de Obras y Servicios Publicos SNC:企業の戦略・SWOT・財務分析
    Banco Nacional de Obras y Servicios Publicos SNC - Strategy, SWOT and Corporate Finance Report Summary Banco Nacional de Obras y Servicios Publicos SNC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Frequency Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Frequency Therapeutics Inc (Frequency Therapeutics) is a biotechnology company that develops progenitor cell activation (PCA) therapies. The company’s small molecule drugs are used to activate progenitor cells for restoration of healthy tissue. Its lead program FX-322 is used to recreate sen …
  • Schweizerische Rettungsflugwacht (Rega):企業の戦略的SWOT分析
    Schweizerische Rettungsflugwacht (Rega) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Shields Bag And Printing Company:企業の戦略・SWOT・財務分析
    Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report Summary Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • CIMIC Group Ltd (CIM):企業の財務・戦略的SWOT分析
    CIMIC Group Ltd (CIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Catholic Health Initiatives:企業の戦略・SWOT・財務分析
    Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report Summary Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆